Published in Medical Device Business Week, September 5th, 2007
Although vital for normal brain function, blood-brain barrier impermeability presents a problem when treating malignant and degenerative disorders of the central nervous system, such as brain cancer, Alzheimer's and Parkinson's disease. Under the terms of this grant, ImaRx will evaluate whether microbubbles and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week